Souza RL, Fonseca-Fonseca T, Oliveira-Santos CC, Corrêa GT, Santos FB, Cardoso CM et al (2011) Lip squamous cell carcinoma in a Brazilian population: epidemiological study and clinicopathological associations. Med oral Patologia oral y Cir Bucal 16(6):e757–e762. https://doi.org/10.4317/medoral.16954
Gilligan G, Panico R, Lazos J, Morelatto R, Belardinelli P, Criscuolo MI et al (2024) Oral squamous cell carcinomas and oral potentially malignant disorders: a latin American study. Oral Dis 30(5):2965–2984. https://doi.org/10.1111/odi.14778
Biasoli ÉR, Valente VB, Mantovan B, Collado FU, Neto SC, Sundefeld ML et al (2016) Lip Cancer: a clinicopathological study and treatment outcomes in a 25-Year experience. J oral Maxillofacial Surgery: Official J Am Association Oral Maxillofacial Surg 74(7):1360–1367. https://doi.org/10.1016/j.joms.2016.01.041
Mello FW, Melo G, Modolo F (2019) Actinic cheilitis and lip squamous cell carcinoma: literature review and new data from Brazil. J Clin Experimental Dentistry 11(1):e62. https://doi.org/10.4317/jced.55133
Strieder L, Coutinho-Camillo CM, Costa V, da Cruz Perez DE, Kowalski LP, Kaminagakura E (2017) Comparative analysis of three histologic grading methods for squamous cell carcinoma of the lip. Oral Dis 23(1):120–125. https://doi.org/10.1111/odi.12586
Article CAS PubMed Google Scholar
Warnakulasuriya S (2018) Clinical features and presentation of oral potentially malignant disorders. Oral Surg oral Med oral Pathol oral Radiol 125(6):582–590. https://doi.org/10.1016/j.oooo.2018.03.011
Rodríguez-Blanco I, Flórez Á, Paredes-Suárez C, Rodríguez-Lojo R, González-Vilas D, Ramírez-Santos A et al (2018) Actinic Cheilitis Prevalence and Risk factors: a cross-sectional, Multicentre Study in a Population aged 45 years and over in North-West Spain. Acta dermato-venereologica 98(10):970–974. https://doi.org/10.2340/00015555-3014
Dancyger A, Heard V, Huang B, Suley C, Tang D, Ariyawardana A (2018) Malignant transformation of actinic cheilitis: a systematic review of observational studies. J Invest Clin Dent 9(4):e12343. https://doi.org/10.1111/jicd.12343
de Santana Sarmento DJ, da Costa Miguel MC, Queiroz LM, Godoy GP, da Silveira EJ (2014) Actinic cheilitis: clinicopathologic profile and association with degree of dysplasia. Int J Dermatol 53(4):466–472. https://doi.org/10.1111/ijd.12332
Varela-Centelles P, Seoane-Romero J, García-Pola MJ, Leira-Feijoo Y, Seoane-Romero JM (2020) Therapeutic approaches for actinic cheilitis: therapeutic efficacy and malignant transformation after treatment. Int J Oral Maxillofac Surg 49(10):1343–1350. https://doi.org/10.1016/j.ijom.2020.02.014
Article CAS PubMed Google Scholar
Li X, Kikuchi K, Takano Y (2011) ING genes work as tumor suppressor genes in the carcinogenesis of head and neck squamous cell carcinoma. J Oncol 2011. https://doi.org/10.1155/2011/963614
Zhang R, Jin J, Shi J, Hou Y (2017) INGs are potential drug targets for cancer. J Cancer Res Clin Oncol 143:189–197. https://doi.org/10.1007/s00432-016-2219-z
Article CAS PubMed Google Scholar
Dantas A, Al Shueili B, Yang Y, Nabbi A, Fink D, Riabowol K (2019) Biological functions of the ING proteins. Cancers 11(11):1817. https://doi.org/10.3390/cancers11111817
Article CAS PubMed PubMed Central Google Scholar
Li X, Zhang Q, Zhang M, Luo Y, Fu Y (2020) Downregulation of nuclear ING3 expression and translocalization to cytoplasm promotes tumorigenesis and progression in head and neck squamous cell carcinoma (HNSCC). Histol Histopathol 35(7):681–690. https://doi.org/10.14670/HH-18-197
Zhou R, Rotte A, Li G, Chen X, Chen G, Bhandaru M (2020) Nuclear localization of ING3 is required to suppress melanoma cell migration, invasion and angiogenesis. Biochem Biophys Res Commun 527(2):418–424. https://doi.org/10.1016/j.bbrc.2020.04.056
Article CAS PubMed Google Scholar
Nabbi A, McClurg UL, Thalappilly S, Almami A, Mobahat M, Bismar TA, Binda O, Riabowol KT (2017) ING3 promotes prostate cancer growth by activating the androgen receptor. BMC Med 15:1–14. https://doi.org/10.1186/s12916-017-0854-0
Yang HY, Liu HL, Tian LT, Song RP, Song X, Yin DL, Liang YJ, Qu LD, Jiang HC, Liu JR, Liu LX (2012) Expression and prognostic value of ING3 in human primary hepatocellular carcinoma. Experimental Biology Med 237(4):352–361. https://doi.org/10.1258/ebm.2011.011346
Wu X, Chen C, Luo B, Yan D, Yan H, Chen F, Guan F, Wu H, Yuan J (2021) Nuclear ING3 expression is correlated with a good prognosis of breast cancer. Front Oncol 10:589009. https://doi.org/10.3389/fonc.2020.589009
Article PubMed PubMed Central Google Scholar
McClurg UL, Nabbi A, Ricordel C, Korolchuk S, McCracken S, Heer R, Wilson L, Butler LM, Irving-Hooper BK, Pedeux R, Robson CN, Riabowol KT, Binda O (2018) Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein. Br J Cancer 118(5):713–726. https://doi.org/10.1038/bjc.2017.447
Article CAS PubMed PubMed Central Google Scholar
El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (2017) World Health Organization classification of tumours: pathology and genetics of head and neck tumours, 4 edn. IARC: Lyon,
Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P (2006) Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol 42(10):987–993. https://doi.org/10.1016/j.oraloncology.2005.12.014
Almangush A, Bello IO, Coletta RD, Mäkitie AA, Mäkinen LK, Kauppila JH, Pukkila M et al (2015) For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality. Virchows Arch 467:39–46. https://doi.org/10.1007/s00428-015-1758-z
Wang C, Huang H, Huang Z, Wang A, Chen X, Huang L, Zhou X, Liu X (2011) Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. J oral Pathol Med 40(7):545–551. https://doi.org/10.1111/j.1600-0714.2011.01041.x
Article PubMed PubMed Central Google Scholar
Gou WF, Yang XF, Shen DF, Zhao S, Sun HZ, Luo JS, Zheng HC (2017) Immunohistochemical profile of ING3 protein in normal and cancerous tissues. Oncol Lett 13(3):1631–1636. https://doi.org/10.3892/ol.2017.5632
Article CAS PubMed PubMed Central Google Scholar
Zhao S, Wang L, Zhang C, Deng Y, Zhao B, Ren Y, Fu Y, Meng X (2018) Inhibitor of growth 3 induces cell death by regulating cell proliferation, apoptosis and cell cycle arrest by blocking the PI3K/AKT pathway. Cancer Gene Ther 25(9–10):240–247. https://doi.org/10.1038/s41417-018-0023-4
Article CAS PubMed Google Scholar
Li H, Zhang H, Tan X, Liu D, Guo R, Wang M, Liu R, Tang S (2021) Overexpression of ING3 is associated with attenuation of migration and invasion in breast cancer. Experimental Therapeutic Med 22(1):1–12. https://doi.org/10.3892/etm.2021.10131
van der Waal I (2009) Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 45(4–5):317–323. https://doi.org/10.1016/j.oraloncology.2008.05.016
Pilati S, Bianco BC, Vieira D, Modolo F (2017) Histopathologic features in actinic cheilitis by the comparison of grading dysplasia systems. Oral Dis 23(2):219–224. https://doi.org/10.1111/odi.12597
Nagata G, Santana T, Queiroz A, Caramez RH, Trierveiler M (2018) Evaluation of epithelial dysplasia adjacent to lip squamous cell carcinoma indicates that the degree of dysplasia is not associated with the occurrence of invasive carcinoma in this site. Journal of cutaneous pathology. Adv Online Publication. https://doi.org/10.1111/cup.13270
Câmara PR, Dutra SN, Takahama Júnior A, Fontes K, Azevedo RS (2016) A comparative study using WHO and binary oral epithelial dysplasia grading systems in actinic cheilitis. Oral Dis 22(6):523–529. https://doi.org/10.1111/odi.12484
Li XH, Li D, Liu C, Zhang MM, Guan XJ, Fu YP (2020) p33ING1b regulates acetylation of p53 in oral squamous cell carcinoma via SIR2. Cancer Cell Int 20(1):1–9. https://doi.org/10.1016/j.bbrc.2008.07.076
Comments (0)